Michael Worley, MD
Gynecologic Oncology · Jupiter, FLNPI 1013157734
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $34,000 of the $34,993 with a category attached, or 97.2%. Medical Device Business Services, Inc. accounts for 81.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $19,376 and has fallen 99.9% since, to $22 in 2025.
Across 28 payments — averaging $1249.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$29K
- Johnson & Johnson$4K
- Coopersurgical, Inc.$2K
- Ethicon Endo-surgery Inc.$250
- AbbVie$92
What the payments were for
- Consulting fees$34,00097%
- Travel & lodging$7022%
- Food & beverage$2911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 15 | $28,576 |
| Johnson & Johnson(2 entities) | 3 | $4,050 |
| Coopersurgical, Inc. | 3 | $2,025 |
| Ethicon Endo-surgery Inc. | 1 | $250 |
| AbbVie | 6 | $92 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,993 in reported general payments places this provider in the 80th percentile of 117 gynecologic oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 48 | $205 |
| Tramadol Hcl | 41 | $62 |
| Oxycodone Hcl | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Jupiter
- Bradley MonkWest Palm Beach$2.5M
- Martin MartinoJacksonville$957K
- Brian SlomovitzFort Lauderdale$519K
- Ricardo EstapeMiami$457K
- Robert HollowayOrlando$432K
- Shelly SewardOrlando$349K
- Edward GrendysFort Myers$341K
- Jonathan BlackMiramar$329K
- Nathalie McKenzieOrlando$223K
- John McBroomNaples$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.